Colony-stimulating factor-2 triggers NNMT-dependent myofibroblast activation in head and neck cancer

Sahai E, Astsaturov I, Cukierman E, DeNardo DG, Egeblad M, Evans RM, et al. A framework for advancing our understanding of cancer-associated fibroblasts. Nat Rev Cancer. 2020;20:174–86.

Article 
CAS 
PubMed 
PubMed Central 

Google Scholar 

Chhabra Y, Weeraratna AT. Fibroblasts in cancer: unity in heterogeneity. Cell. 2023;186:1580–609.

Article 
CAS 
PubMed 
PubMed Central 

Google Scholar 

Chen Y, McAndrews KM, Kalluri R. Clinical and therapeutic relevance of cancer-associated fibroblasts. Nat Rev Clin Oncol. 2021;18:792–804.

Article 
CAS 
PubMed 
PubMed Central 

Google Scholar 

Heide J, Bilecz AJ, Patnaik S, Allega MF, Donle L, Yang K, et al. NNMT inhibition in cancer-associated fibroblasts restores antitumour immunity. 2025;645:1051–9.

Eckert MA, Coscia F, Chryplewicz A, Chang JW, Hernandez KM, Pan S, et al. Proteomics reveals NNMT as a master metabolic regulator of cancer-associated fibroblasts. Nature. 2019;569:723–8.

Article 
CAS 
PubMed 
PubMed Central 

Google Scholar 

Zhao H, Li R, Chen Y, Yang X, Shang Z. Stromal nicotinamide N-methyltransferase orchestrates the crosstalk between fibroblasts and tumour cells in oral squamous cell carcinoma: evidence from patient-derived assembled organoids. Oncogene. 2023;42:1166–80.

Article 
CAS 
PubMed 

Google Scholar 

Wang X, Zhao H, Luo X, Chen Y, Shi C, Wang Y, et al. NNMT switches the proangiogenic phenotype of cancer-associated fibroblasts via epigenetically regulating the ETS2/VEGFA axis. Oncogene. 2024;43:2647–60.

Article 
CAS 
PubMed 

Google Scholar 

Öhlund D, Handly-Santana A, Biffi G, Elyada E, Almeida AS, Ponz-Sarvise M, et al. Distinct populations of inflammatory fibroblasts and myofibroblasts in pancreatic cancer. J Exp Med. 2017;214:579–96.

Article 
PubMed 
PubMed Central 

Google Scholar 

Biffi G, Oni TE, Spielman B, Hao Y, Elyada E, Park Y, et al. IL1-induced JAK/STAT signaling is antagonized by TGFβ to shape CAF heterogeneity in pancreatic ductal adenocarcinoma. Cancer Discov. 2019;9:282–301. Feb.

Article 
PubMed 

Google Scholar 

Park D, Sahai E, Rullan A. SnapShot: cancer-associated fibroblasts. Cell. 2020;181:486–486.e1.

Article 
CAS 
PubMed 

Google Scholar 

Puram SV, Tirosh I, Parikh AS, Patel AP, Yizhak K, Gillespie S, et al. Single-cell transcriptomic analysis of primary and metastatic tumor ecosystems in head and neck. Cancer Cell. 2017;171:1611–1624.e24.

Article 
CAS 

Google Scholar 

Choi JH, Lee BS, Jang JY, Lee YS, Kim HJ, Roh J, et al. Single-cell transcriptome profiling of the stepwise progression of head and neck cancer. Nat Commun. 2023;14:1055.

Article 
CAS 
PubMed 
PubMed Central 

Google Scholar 

Hasan S, Buechler MB. What’s in a name? An emerging framework for cancer-associated fibroblasts, myofibroblasts, and fibroblasts. Cancer Cell. 2022;40:1273–5.

Article 
CAS 
PubMed 

Google Scholar 

Mucciolo G, Araos Henríquez J, Jihad M, Pinto Teles S, Manansala JS, Li W, et al. EGFR-activated myofibroblasts promote metastasis of pancreatic cancer. Cancer Cell. 2024;42:101–118.e11.

Article 
CAS 
PubMed 

Google Scholar 

Mellone M, Piotrowska K, Venturi G, James L, Bzura A, Lopez MA, et al. ATM regulates differentiation of myofibroblastic cancer-associated fibroblasts and can be targeted to overcome immunotherapy resistance. Cancer Res. 2022;82:4571–85.

Article 
CAS 
PubMed 
PubMed Central 

Google Scholar 

Lee KW, Yeo SY, Gong JR, Koo OJ, Sohn I, Lee WY, et al. PRRX1 is a master transcription factor of stromal fibroblasts for myofibroblastic lineage progression. Nat Commun. 2022;13:2793.

Article 
CAS 
PubMed 
PubMed Central 

Google Scholar 

Wu J, Jing X, Du Q, Sun X, Holgersson K, Gao J, et al. Disruption of the clock component Bmal1 in mice promotes cancer metastasis through the PAI-1-TGF-β-myoCAF-dependent mechanism. Adv Sci. 2023;10:e2301505.

Article 

Google Scholar 

Tomasek JJ, Gabbiani G, Hinz B, Chaponnier C, Brown RA. Myofibroblasts and mechano-regulation of connective tissue remodelling. Nat Rev Mol Cell Biol. 2002;3:349–63.

Article 
CAS 
PubMed 

Google Scholar 

Arora R, Cao C, Kumar M, Sinha S, Chanda A, McNeil R, et al. Spatial transcriptomics reveals distinct and conserved tumor core and edge architectures that predict survival and targeted therapy response. Nat Commun. 2023;14:5029.

Article 
CAS 
PubMed 
PubMed Central 

Google Scholar 

Catenacci DVT, Junttila MR, Karrison T, Bahary N, Horiba MN, Nattam SR, et al. Randomized phase Ib/II study of gemcitabine plus placebo or vismodegib, a hedgehog pathway inhibitor, in patients with metastatic pancreatic cancer. J Clin Oncol. 2015;33:4284–92.

Article 
CAS 
PubMed 
PubMed Central 

Google Scholar 

Benson AB, Wainberg ZA, Hecht JR, Vyushkov D, Dong H, Bendell J, et al. A phase II randomized, double-blind, placebo-controlled study of simtuzumab or placebo in combination with gemcitabine for the first-line treatment of pancreatic adenocarcinoma. Oncologist. 2017;22:241–e15.

Article 
CAS 
PubMed 
PubMed Central 

Google Scholar 

Ko AH, LoConte N, Tempero MA, Walker EJ, Kate Kelley R, Lewis S, et al. A phase I study of FOLFIRINOX plus IPI-926, a hedgehog pathway inhibitor, for advanced pancreatic adenocarcinoma. Pancreas. 2016;45:370–5.

Article 
CAS 
PubMed 
PubMed Central 

Google Scholar 

Özdemir BC, Pentcheva-Hoang T, Carstens JL, Zheng X, Wu CC, Simpson TR, et al. Depletion of carcinoma-associated fibroblasts and fibrosis induces immunosuppression and accelerates pancreas cancer with reduced survival. Cancer Cell. 2014;25:719–34.

Article 
PubMed 
PubMed Central 

Google Scholar 

Pissios P. Nicotinamide N-methyltransferase: more than a vitamin B3 clearance enzyme. Trends Endocrinol Metab. 2017;28:340–53.

Article 
CAS 
PubMed 
PubMed Central 

Google Scholar 

Ulanovskaya OA, Zuhl AM, Cravatt BF. NNMT promotes epigenetic remodeling in cancer by creating a metabolic methylation sink. Nat Chem Biol. 2013;9:300–6.

Article 
CAS 
PubMed 
PubMed Central 

Google Scholar 

Wang Z, Wang Q, Chen C, Zhao X, Wang H, Xu L, et al. NNMT enriches for AQP5+ cancer stem cells to drive malignant progression in early gastric cardia adenocarcinoma. Gut. 2023;73:63–77.

Ma Y, Huang X, Wang Y, Lei Y, Yu J, Yu S, et al. NNMT/1-MNA promotes cell-cycle progression of breast cancer by targeting UBC12/cullin-1-mediated degradation of P27 proteins. Adv Sci. 2024;11:e2305907.

Article 

Google Scholar 

Luo X, Chen Y, Tang H, Wang H, Jiang E, Shao Z, et al. Melatonin inhibits EMT and PD-L1 expression through the ERK1/2/FOSL1 pathway and regulates anti-tumor immunity in HNSCC. Cancer Sci. 2022;113:2232–45.

Article 
CAS 
PubMed 
PubMed Central 

Google Scholar 

Chen X, Li R, Zhao H, Wang X, Shao Z, Shang Z. Phenotype transition of fibroblasts incorporated into patient-derived oral carcinoma organoids. Oral Dis. 2023;29:913–22.

Article 
PubMed 

Google Scholar 

Yang X, Zhao H, Li R, Chen Y, Xu Z, Shang Z. Stromal thrombospondin 1 suppresses angiogenesis in oral submucous fibrosis. Int J Oral Sci. 2024;16:17.

Article 
PubMed 
PubMed Central 

Google Scholar 

Tomida M, Ohtake H, Yokota T, Kobayashi Y, Kurosumi M. Stat3 up-regulates expression of nicotinamide N-methyltransferase in human cancer cells. J Cancer Res Clin Oncol. 2008;134:551–9.

Article 
CAS 
PubMed 

Google Scholar 

Sasaki T, Kojima H, Kishimoto R, Ikeda A, Kunimoto H, Nakajima K. Spatiotemporal regulation of c-Fos by ERK5 and the E3 ubiquitin ligase UBR1, and its biological role. Mol Cell. 2006;24:63–75.

Article 
CAS 
PubMed 

Google Scholar 

Metcalf D. The colony-stimulating factors and cancer. Cancer Immunol Res. 2013;1:351–6.

Article 
CAS 
PubMed 
PubMed Central 

Google Scholar 

Gallo-Oller G, Vollmann-Zwerenz A, Meléndez B, Rey JA, Hau P, Dotor J, et al. P144, a transforming growth factor beta inhibitor peptide, generates antitumoral effects and modifies SMAD7 and SKI levels in human glioblastoma cell lines. Cancer Lett. 2016;381:67–75.

Article 
CAS 
PubMed 

Google Scholar 

Wang TT, Zhao YL, Peng LS, Chen N, Chen W, Lv YP, et al. Tumour-activated neutrophils in gastric cancer foster immune suppression and disease progression through GM-CSF-PD-L1 pathway. Gut. 2017;66:1900–11.

Article 
CAS 
PubMed 
PubMed Central 

Google Scholar 

Kumar V, Donthireddy L, Marvel D, Condamine T, Wang F, Lavilla-Alonso S, et al. Cancer-associated fibroblasts neutralize the anti-tumor effect of CSF1 receptor blockade by inducing PMN-MDSC infiltration of tumors. Cancer Cell. 2017;32:654–668.e5.

Article 
CAS 
PubMed 
PubMed Central 

Google Scholar 

Becher B, Tugues S, Greter M. GM-CSF: From growth factor to central mediator of tissue inflammation. Immunity. 2016;45:963–73.

Article 
CAS 
PubMed 

Google Scholar 

Rhim AD, Oberstein PE, Thomas DH, Mirek ET, Palermo CF, Sastra SA, et al. Stromal elements act to restrain, rather than support, pancreatic ductal adenocarcinoma. Cancer Cell. 2014;25:735–47.

Article 
CAS 
PubMed 
PubMed Central 

Google Scholar 

Lee JJ, Perera RM, Wang H, Wu DC, Liu XS, Han S, et al. Stromal response to Hedgehog signaling restrains pancreatic cancer progression. Proc Natl Acad Sci USA. 2014;111:E3091–3100.

Article 
CAS 
PubMed 
PubMed Central 

Google Scholar 

Farin HF, Mosa MH, Ndreshkjana B, Grebbin BM, Ritter B, Menche C, et al. Colorectal cancer organoid-stroma biobank allows subtype-specific assessment of individualized therapy responses. Cancer Discov. 2023;13:2192–211.

Article 
PubMed 
PubMed Central 

Google Scholar 

Sharbeen G, McCarroll JA, Akerman A, Kopecky C, Youkhana J, Kokkinos J, et al. Cancer-associated fibroblasts in pancreatic ductal adenocarcinoma determine response to SLC7A11 inhibition. Cancer Res. 2021;81:3461–79.

Article 
CAS 
PubMed 

Google Scholar